This FAQ explains how the conclusion of Amin et al. conflicts with more robust, previously published, FDA-audited, peer-reviewed, real-world studies and RCTs.
This FAQ explains how the conclusions of Dhruva et al. conflict with Impella® best practice outcomes reported in more robust, previously published, contemporary, prospective studies.
Jo Kajewski, advanced Impella trainer, discusses how Impella should appear on baseline echo and steps for repositioning Impella if a positioning alarm occur.
Amir Kaki, MD discusses tips, tricks and techniques for high-risk PCI including access, implant, explant, closure, and complications and sheath management.
This FAQ discusses bleeding rates associated with mechanical circulatory support and vascular access and closure techniques for successfully managing bleeding.
The goals of cardiogenic shock treatment are to restore blood flow and protect organs from damage. Learn more about signs, symptoms and treatment options.
NPS-1674
The Protected PCI community
is now on HeartRecovery.com
Providing education and training to help health care professionals
recover hearts, oxygenate the body and save lives.